 | • レポートコード：MRC22NVL18383 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の持続的投与型薬物送達システム（DDS）の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の持続的投与型薬物送達システム（DDS）市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の持続的投与型薬物送達システム（DDS）市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の持続的投与型薬物送達システム（DDS）市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の持続的投与型薬物送達システム（DDS）市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の持続的投与型薬物送達システム（DDS）の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な持続的投与型薬物送達システム（DDS）プレーヤーとして、West Pharmaceutical Services、 Cirtec Medical、 Balda、 Lubrizol、 Beckman Coulter、 Scios、 Noven Pharmaceuticals、 Raritan Pharmaceuticals、 Parker Hannifin、 Nitto Avecia Pharma Services、 KV Pharmaceutical、 Equashield、 Shire Laboratories、 Powder Systems、 B. Braun OEM Division、 Pharmaco-Kinesis、 Foresee、 Bayer、 Catalent、 Pfizeなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの持続的投与型薬物送達システム（DDS）市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 非生分解性埋め込み型、生分解性埋め込み型、マイクロ粒子・ナノ粒子、リポソーム、ECT 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 病院、診療所、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：持続的投与型薬物送達システム（DDS）の年間販売量2017-2028、地域別現状・将来分析 ・持続的投与型薬物送達システム（DDS）のタイプ別セグメント：非生分解性埋め込み型、生分解性埋め込み型、マイクロ粒子・ナノ粒子、リポソーム、ECT ・持続的投与型薬物送達システム（DDS）のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・持続的投与型薬物送達システム（DDS）の用途別セグメント：病院、診療所、その他 ・持続的投与型薬物送達システム（DDS）の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の持続的投与型薬物送達システム（DDS）市場 ・企業別のグローバル持続的投与型薬物送達システム（DDS）市場データ：2020-2022年の年間販売量、市場シェア ・企業別の持続的投与型薬物送達システム（DDS）の年間売上：2020-2022年の売上、市場シェア ・企業別の持続的投与型薬物送達システム（DDS）販売価格 ・主要企業の持続的投与型薬物送達システム（DDS）生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 持続的投与型薬物送達システム（DDS）の地域別レビュー ・地域別の持続的投与型薬物送達システム（DDS）市場規模2017-2022：年間販売量、売上 ・主要国別の持続的投与型薬物送達システム（DDS）市場規模2017-2022：年間販売量、売上 ・南北アメリカの持続的投与型薬物送達システム（DDS）販売の成長 ・アジア太平洋の持続的投与型薬物送達システム（DDS）販売の成長 ・欧州の持続的投与型薬物送達システム（DDS）販売の成長 ・中東・アフリカの持続的投与型薬物送達システム（DDS）販売の成長 南北アメリカ市場 ・南北アメリカの国別の持続的投与型薬物送達システム（DDS）販売量、売上（2017-2022） ・南北アメリカの持続的投与型薬物送達システム（DDS）の種類別販売量 ・南北アメリカの持続的投与型薬物送達システム（DDS）の用途別販売量 ・米国の持続的投与型薬物送達システム（DDS）市場 ・カナダの持続的投与型薬物送達システム（DDS）市場 ・メキシコの持続的投与型薬物送達システム（DDS）市場 ・ブラジルの持続的投与型薬物送達システム（DDS）市場 アジア太平洋市場 ・アジア太平洋の国別の持続的投与型薬物送達システム（DDS）販売量、売上（2017-2022） ・アジア太平洋の持続的投与型薬物送達システム（DDS）の種類別販売量 ・アジア太平洋の持続的投与型薬物送達システム（DDS）の用途別販売量 ・中国市場の持続的投与型薬物送達システム（DDS）市場 ・日本市場の持続的投与型薬物送達システム（DDS）市場 ・韓国市場の持続的投与型薬物送達システム（DDS）市場 ・東南アジアの持続的投与型薬物送達システム（DDS）市場 ・インドの持続的投与型薬物送達システム（DDS）市場 ・オーストラリアの持続的投与型薬物送達システム（DDS）市場 ・台湾の持続的投与型薬物送達システム（DDS）市場 欧州市場 ・欧州の国別の持続的投与型薬物送達システム（DDS）販売量、売上（2017-2022） ・欧州の持続的投与型薬物送達システム（DDS）の種類別販売量 ・欧州の持続的投与型薬物送達システム（DDS）の用途別販売量 ・ドイツの持続的投与型薬物送達システム（DDS）市場 ・フランスの持続的投与型薬物送達システム（DDS）市場 ・イギリスの持続的投与型薬物送達システム（DDS）市場 ・イタリアの持続的投与型薬物送達システム（DDS）市場 ・ロシアの持続的投与型薬物送達システム（DDS）市場 中東・アフリカ市場 ・中東・アフリカの国別の持続的投与型薬物送達システム（DDS）販売量、売上（2017-2022） ・中東・アフリカの持続的投与型薬物送達システム（DDS）の種類別販売量 ・中東・アフリカの持続的投与型薬物送達システム（DDS）の用途別販売量 ・エジプトの持続的投与型薬物送達システム（DDS）市場 ・南アフリカの持続的投与型薬物送達システム（DDS）市場 ・イスラエルの持続的投与型薬物送達システム（DDS）市場 ・トルコの持続的投与型薬物送達システム（DDS）市場 ・GCC諸国の持続的投与型薬物送達システム（DDS）市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・持続的投与型薬物送達システム（DDS）の製造コスト構造分析 ・持続的投与型薬物送達システム（DDS）の製造プロセス分析 ・持続的投与型薬物送達システム（DDS）の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・持続的投与型薬物送達システム（DDS）の主要なグローバル販売業者 ・持続的投与型薬物送達システム（DDS）の主要なグローバル顧客 地域別の持続的投与型薬物送達システム（DDS）市場予測レビュー ・地域別の持続的投与型薬物送達システム（DDS）市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・持続的投与型薬物送達システム（DDS）のタイプ別市場規模予測 ・持続的投与型薬物送達システム（DDS）の用途別市場規模予測 主要企業分析 West Pharmaceutical Services、 Cirtec Medical、 Balda、 Lubrizol、 Beckman Coulter、 Scios、 Noven Pharmaceuticals、 Raritan Pharmaceuticals、 Parker Hannifin、 Nitto Avecia Pharma Services、 KV Pharmaceutical、 Equashield、 Shire Laboratories、 Powder Systems、 B. Braun OEM Division、 Pharmaco-Kinesis、 Foresee、 Bayer、 Catalent、 Pfize ・企業情報 ・持続的投与型薬物送達システム（DDS）製品 ・持続的投与型薬物送達システム（DDS）販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Sustained Release Drug Delivery Systems will have significant change from previous year. According to our (LP Information) latest study, the global Sustained Release Drug Delivery Systems market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sustained Release Drug Delivery Systems market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sustained Release Drug Delivery Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sustained Release Drug Delivery Systems market, reaching US$ million by the year 2028. As for the Europe Sustained Release Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sustained Release Drug Delivery Systems players cover West Pharmaceutical Services, Cirtec Medical, Balda, and Lubrizol, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sustained Release Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nonbiodegradable Implants
Biodegradable Implants
Micro- and Nano-Particles
Liposomes
ECT
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
West Pharmaceutical Services
Cirtec Medical
Balda
Lubrizol
Beckman Coulter
Scios
Noven Pharmaceuticals
Raritan Pharmaceuticals
Parker Hannifin
Nitto Avecia Pharma Services
KV Pharmaceutical
Equashield
Shire Laboratories
Powder Systems
B. Braun OEM Division
Pharmaco-Kinesis
Foresee
Bayer
Catalent
Pfizer
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sustained Release Drug Delivery Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sustained Release Drug Delivery Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sustained Release Drug Delivery Systems by Country/Region, 2017, 2022 & 2028
2.2 Sustained Release Drug Delivery Systems Segment by Type
2.2.1 Nonbiodegradable Implants
2.2.2 Biodegradable Implants
2.2.3 Micro- and Nano-Particles
2.2.4 Liposomes
2.2.5 ECT
2.3 Sustained Release Drug Delivery Systems Sales by Type
2.3.1 Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Sustained Release Drug Delivery Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sustained Release Drug Delivery Systems Sale Price by Type (2017-2022)
2.4 Sustained Release Drug Delivery Systems Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Sustained Release Drug Delivery Systems Sales by Application
2.5.1 Global Sustained Release Drug Delivery Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Sustained Release Drug Delivery Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sustained Release Drug Delivery Systems Sale Price by Application (2017-2022)
3 Global Sustained Release Drug Delivery Systems by Company
3.1 Global Sustained Release Drug Delivery Systems Breakdown Data by Company
3.1.1 Global Sustained Release Drug Delivery Systems Annual Sales by Company (2020-2022)
3.1.2 Global Sustained Release Drug Delivery Systems Sales Market Share by Company (2020-2022)
3.2 Global Sustained Release Drug Delivery Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Sustained Release Drug Delivery Systems Revenue by Company (2020-2022)
3.2.2 Global Sustained Release Drug Delivery Systems Revenue Market Share by Company (2020-2022)
3.3 Global Sustained Release Drug Delivery Systems Sale Price by Company
3.4 Key Manufacturers Sustained Release Drug Delivery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sustained Release Drug Delivery Systems Product Location Distribution
3.4.2 Players Sustained Release Drug Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sustained Release Drug Delivery Systems by Geographic Region
4.1 World Historic Sustained Release Drug Delivery Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Sustained Release Drug Delivery Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sustained Release Drug Delivery Systems Annual Revenue by Geographic Region
4.2 World Historic Sustained Release Drug Delivery Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Sustained Release Drug Delivery Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sustained Release Drug Delivery Systems Annual Revenue by Country/Region
4.3 Americas Sustained Release Drug Delivery Systems Sales Growth
4.4 APAC Sustained Release Drug Delivery Systems Sales Growth
4.5 Europe Sustained Release Drug Delivery Systems Sales Growth
4.6 Middle East & Africa Sustained Release Drug Delivery Systems Sales Growth
5 Americas
5.1 Americas Sustained Release Drug Delivery Systems Sales by Country
5.1.1 Americas Sustained Release Drug Delivery Systems Sales by Country (2017-2022)
5.1.2 Americas Sustained Release Drug Delivery Systems Revenue by Country (2017-2022)
5.2 Americas Sustained Release Drug Delivery Systems Sales by Type
5.3 Americas Sustained Release Drug Delivery Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sustained Release Drug Delivery Systems Sales by Region
6.1.1 APAC Sustained Release Drug Delivery Systems Sales by Region (2017-2022)
6.1.2 APAC Sustained Release Drug Delivery Systems Revenue by Region (2017-2022)
6.2 APAC Sustained Release Drug Delivery Systems Sales by Type
6.3 APAC Sustained Release Drug Delivery Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sustained Release Drug Delivery Systems by Country
7.1.1 Europe Sustained Release Drug Delivery Systems Sales by Country (2017-2022)
7.1.2 Europe Sustained Release Drug Delivery Systems Revenue by Country (2017-2022)
7.2 Europe Sustained Release Drug Delivery Systems Sales by Type
7.3 Europe Sustained Release Drug Delivery Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sustained Release Drug Delivery Systems by Country
8.1.1 Middle East & Africa Sustained Release Drug Delivery Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sustained Release Drug Delivery Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Sustained Release Drug Delivery Systems Sales by Type
8.3 Middle East & Africa Sustained Release Drug Delivery Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sustained Release Drug Delivery Systems
10.3 Manufacturing Process Analysis of Sustained Release Drug Delivery Systems
10.4 Industry Chain Structure of Sustained Release Drug Delivery Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sustained Release Drug Delivery Systems Distributors
11.3 Sustained Release Drug Delivery Systems Customer
12 World Forecast Review for Sustained Release Drug Delivery Systems by Geographic Region
12.1 Global Sustained Release Drug Delivery Systems Market Size Forecast by Region
12.1.1 Global Sustained Release Drug Delivery Systems Forecast by Region (2023-2028)
12.1.2 Global Sustained Release Drug Delivery Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sustained Release Drug Delivery Systems Forecast by Type
12.7 Global Sustained Release Drug Delivery Systems Forecast by Application
13 Key Players Analysis
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services Sustained Release Drug Delivery Systems Product Offered
13.1.3 West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Cirtec Medical
13.2.1 Cirtec Medical Company Information
13.2.2 Cirtec Medical Sustained Release Drug Delivery Systems Product Offered
13.2.3 Cirtec Medical Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cirtec Medical Main Business Overview
13.2.5 Cirtec Medical Latest Developments
13.3 Balda
13.3.1 Balda Company Information
13.3.2 Balda Sustained Release Drug Delivery Systems Product Offered
13.3.3 Balda Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Balda Main Business Overview
13.3.5 Balda Latest Developments
13.4 Lubrizol
13.4.1 Lubrizol Company Information
13.4.2 Lubrizol Sustained Release Drug Delivery Systems Product Offered
13.4.3 Lubrizol Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lubrizol Main Business Overview
13.4.5 Lubrizol Latest Developments
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Information
13.5.2 Beckman Coulter Sustained Release Drug Delivery Systems Product Offered
13.5.3 Beckman Coulter Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Beckman Coulter Main Business Overview
13.5.5 Beckman Coulter Latest Developments
13.6 Scios
13.6.1 Scios Company Information
13.6.2 Scios Sustained Release Drug Delivery Systems Product Offered
13.6.3 Scios Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Scios Main Business Overview
13.6.5 Scios Latest Developments
13.7 Noven Pharmaceuticals
13.7.1 Noven Pharmaceuticals Company Information
13.7.2 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product Offered
13.7.3 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Noven Pharmaceuticals Main Business Overview
13.7.5 Noven Pharmaceuticals Latest Developments
13.8 Raritan Pharmaceuticals
13.8.1 Raritan Pharmaceuticals Company Information
13.8.2 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product Offered
13.8.3 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Raritan Pharmaceuticals Main Business Overview
13.8.5 Raritan Pharmaceuticals Latest Developments
13.9 Parker Hannifin
13.9.1 Parker Hannifin Company Information
13.9.2 Parker Hannifin Sustained Release Drug Delivery Systems Product Offered
13.9.3 Parker Hannifin Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Parker Hannifin Main Business Overview
13.9.5 Parker Hannifin Latest Developments
13.10 Nitto Avecia Pharma Services
13.10.1 Nitto Avecia Pharma Services Company Information
13.10.2 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product Offered
13.10.3 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nitto Avecia Pharma Services Main Business Overview
13.10.5 Nitto Avecia Pharma Services Latest Developments
13.11 KV Pharmaceutical
13.11.1 KV Pharmaceutical Company Information
13.11.2 KV Pharmaceutical Sustained Release Drug Delivery Systems Product Offered
13.11.3 KV Pharmaceutical Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 KV Pharmaceutical Main Business Overview
13.11.5 KV Pharmaceutical Latest Developments
13.12 Equashield
13.12.1 Equashield Company Information
13.12.2 Equashield Sustained Release Drug Delivery Systems Product Offered
13.12.3 Equashield Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Equashield Main Business Overview
13.12.5 Equashield Latest Developments
13.13 Shire Laboratories
13.13.1 Shire Laboratories Company Information
13.13.2 Shire Laboratories Sustained Release Drug Delivery Systems Product Offered
13.13.3 Shire Laboratories Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shire Laboratories Main Business Overview
13.13.5 Shire Laboratories Latest Developments
13.14 Powder Systems
13.14.1 Powder Systems Company Information
13.14.2 Powder Systems Sustained Release Drug Delivery Systems Product Offered
13.14.3 Powder Systems Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Powder Systems Main Business Overview
13.14.5 Powder Systems Latest Developments
13.15 B. Braun OEM Division
13.15.1 B. Braun OEM Division Company Information
13.15.2 B. Braun OEM Division Sustained Release Drug Delivery Systems Product Offered
13.15.3 B. Braun OEM Division Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 B. Braun OEM Division Main Business Overview
13.15.5 B. Braun OEM Division Latest Developments
13.16 Pharmaco-Kinesis
13.16.1 Pharmaco-Kinesis Company Information
13.16.2 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product Offered
13.16.3 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Pharmaco-Kinesis Main Business Overview
13.16.5 Pharmaco-Kinesis Latest Developments
13.17 Foresee
13.17.1 Foresee Company Information
13.17.2 Foresee Sustained Release Drug Delivery Systems Product Offered
13.17.3 Foresee Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Foresee Main Business Overview
13.17.5 Foresee Latest Developments
13.18 Bayer
13.18.1 Bayer Company Information
13.18.2 Bayer Sustained Release Drug Delivery Systems Product Offered
13.18.3 Bayer Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Bayer Main Business Overview
13.18.5 Bayer Latest Developments
13.19 Catalent
13.19.1 Catalent Company Information
13.19.2 Catalent Sustained Release Drug Delivery Systems Product Offered
13.19.3 Catalent Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Catalent Main Business Overview
13.19.5 Catalent Latest Developments
13.20 Pfizer
13.20.1 Pfizer Company Information
13.20.2 Pfizer Sustained Release Drug Delivery Systems Product Offered
13.20.3 Pfizer Sustained Release Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Pfizer Main Business Overview
13.20.5 Pfizer Latest Developments
14 Research Findings and Conclusion